What will it take?

What will it take?

As Ozempic, Wegovy, Mounjaro and Zepbound continue to rake in billions it’s not surprising that everyone wants a piece of the weight loss action. However, what most of the possible competitors don’t seem to understand is just matching the weight loss isn’t enough. As we are learning these drugs do not just help patients with diabetes and provide weight loss. These drugs also help with sleep apnea, carry cardiovascular benefits, have potential to be used a treatment for addictions, etc.

We are also learning that weekly administration isn’t much of an issue and while everyone complains . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.